ARGS

Argos Therapeutics, Inc.
ARGS

Overview Fund Activity
Delisted

ARGS was delisted on the 24th of April, 2018.

Back to rankings

21 hedge funds and large institutions have $25.7M invested in Argos Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-4
Holders Change %
-16%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
7
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WA
Wasatch Advisors
Utah
$18.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
$1.54M
3
BCM
Bridgeway Capital Management
Texas
$521K
4
Bank of New York Mellon
Bank of New York Mellon
New York
$117K
5
KeyBank National Association
KeyBank National Association
Ohio
$227K

Top Sellers

1
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$0
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
$0
3
WSA
Wall Street Associates
California
$1.24M
4
AGA
Altrinsic Global Advisors
Connecticut
$1.1M
5
FG
Formula Growth
Quebec, Canada
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SIM
26
Spark Investment Management
New York
– -$79K -1,718 Closed
SIP
27
Stoneridge Investment Partners
Pennsylvania
– -$55K -1,182 Closed
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
– -$20K -436 Closed
First Manhattan
29
First Manhattan
New York
– -$2K -50 Closed
Bank of America
30
Bank of America
North Carolina
– -$1K -15 Closed
1
2